Equistone Partners Europe (Equistone) has appointed Sebastien Leusch as Investment Director to its Manchester office as the firm continues to seek new investments from its EUR2 billion Fund V. Leusch joins Equistone having previously worked at Montagu Private Equity, where he spent nine years developing a strong reputation for delivering transactions across a broad range of sectors in the North of England and Europe. Completed deals include the MBOs of Paris-based low fat and healthy spreads manufacturer, St Hubert, and Poland’s leading owner and operator of transmission towers, Emitel, at an enterprise value of EUR430 million and EUR425 million respectively.

Maven Capital Partners has appointed Alex Marsh to its investment team in the North East, as Investment Manager to transact on behalf of Maven’s private equity funds and help manage the GBP20 million Finance Durham Fund, announced earlier this year by Business Durham. Marsh joins from Northstar Ventures, a North East-based venture capital investor focussed on the digital and technology sector, where he invested in early stage businesses to support a range of innovative, high growth companies and prepared portfolio companies for exits.  Previously at PwC for almost 10 years, Alex worked as a Corporate Finance Manager in the award

HarbourVest Partners, a global private markets asset manager, has appointed Simon Jennings as a Managing Director. Based in London, Jennings will focus on business development with distribution partners in Europe and Asia to help their private wealth clients achieve their private markets objectives. “Over the last three decades, and especially more recently, HarbourVest has worked closely with market intermediaries globally to help meet the private markets investment needs of their family office, private bank, wealth management and institutional clients,” says Peter Wilson, Managing Director and member of the Executive Management Committee, HarbourVest. “Simon understands the needs of this market segment

Epidarex Capital (Epidarex), an early-stage, transatlantic life science venture fund, has appointed Dr William R Sellers, William Burns and Dr. Frank M Armstrong to its advisory board. Epidarex is a leading investor in high growth life science and health technologies in under-ventured markets. The advisory board provides strategic guidance and advice to Epidarex and its transatlantic portfolio of 14 early-stage life science companies.   Kyp Sirinakis, Managing Partner and co-founder of Epidarex, says: “As a leading, early-stage venture capital firm, Epidarex builds high-growth life science companies in under-ventured markets. We are delighted to welcome our new advisory board members and

Waterland Private Equity Investments has moved to a new permanent UK office and unveiled a new UK team that is looking to partner with entrepreneurial companies in the UK and Ireland. The European-wide private equity fund manager recently closed its seventh fund (WPEF VII), at EUR2 billion, after less than two months of fundraising, and attracted investment from Europe, the US, the Middle East and Asia.    Waterland UK focuses on sourcing buy-and-build opportunities across the UK and Ireland, typically concerning companies with EBITDA of between GBP3 million and GBP10 million. Waterland is an active shareholder across its portfolio, playing

Kewsong Lee and Glenn A Youngkin are to become Co-Chief Executive Officers of The Carlyle Group, while Peter J Clare will become Co-Chief Investment Officer alongside current CIO William E Conway, Jr. Carlyle’s current Chairman Daniel A D’Aniello will become Chairman Emeritus and continue to serve on the Carlyle Board and Executive Group, while current Co-CEOs David M. Rubenstein and William E. Conway, Jr. will become Co-Executive Chairmen of the Board and continue to serve on the Carlyle Executive Group. Youngkin, Lee and Clare are all joining the Carlyle Board of Directors Conway, D’Aniello and Rubenstein, say: “These promotions ensure

Adams Street Partners, a private markets investment management firm, has appointed Alex Kessel as a Principal on its Co-Investment Team. Kessel joins a growing, dedicated global team lead by David Brett, Partner and Head of Co-Investment at Adams Street Partners. Kessel will be actively involved in the sourcing, screening, execution, monitoring and exiting of growth and later-stage co-investments.   Before joining Adams Street, Kessel was a Principal at Baird Capital, the direct private investment arm of Robert W. Baird & Co, where he co-led the healthcare sector strategy and also had experience in the technology and services, and industrial sectors. Prior to Baird

Sell-side M&A advisor firm Cavendish Corporate Finance has promoted corporate finance professional Jon Edirmanasinghe to Partner. Edirmanasinghe covers a variety of sectors having completed transactions across TMT, Consumer, Healthcare, Financial Services and Business Services. He joined Cavendish in October 2013 as an Executive and his promotion to Partner just four years later is a testament to the outstanding quality of his work and performance in this time.   Prior to joining Cavendish, Edirmanasinghe was a Manager at Ernst & Young’s Financial Services Office in the Cayman Islands for three years, focusing on the hedge fund and private equity sectors. His previous

Muller’s appointment is part of Capzanine’s desire to institutionalise its relationship with its growing number of investors, providing them with a designated point of contact on a daily basis to help guide their investment decisions. Muller says: “My role is to establish and develop a close and valuable relationship with our investors, offering insightful, responsive discussion, and remaining at their disposal at all times to answer any questions they may have.”   Muller has extensive experience with institutional investors. He began his career in 1997 as a stockbroker in London, before joining the buy side in 2001 as Head of